| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | J Wang | |
| P Evans | |||
| C Carroll | |||
| F Morris | |||
| P Thokala | |||
| S Goodacre | |||
| P Collinson | |||
| J Leaviss | |||
| J W Stevens | |||
| M Al Khalaf | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| systematic review | Q1504425 | ||
| P304 | page(s) | v-vi, 1-188 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Health Technology Assessment | Q15708880 |
| P1476 | title | Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome | |
| P478 | volume | 17 |
| Q38178539 | "Troponin elevation in coronary ischemia and necrosis". |
| Q33735504 | A Rational Adoption of the High Sensitive Assay for Cardiac Troponin I in Diagnostic Routine. |
| Q22252541 | A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction |
| Q27014824 | An historical approach to the diagnostic biomarkers of acute coronary syndrome |
| Q38224400 | Assessing the value of cardiac biomarkers: going beyond diagnostic accuracy? |
| Q47414008 | Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome |
| Q38232835 | Cardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome |
| Q26771814 | Chest pain and high-sensitivity troponin: What is the evidence? |
| Q41928326 | Clinical implications of tenascin-C and OX40 ligand in patients with acute coronary syndrome |
| Q33601439 | Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction |
| Q53099474 | Computed tomography coronary angiography: is it such a useful test for emergency department chest pain patients? |
| Q34781673 | Cost consequences of point-of-care troponin T testing in a Swedish primary health care setting |
| Q92451023 | Cost-minimisation analysis alongside a pilot study of early Tissue Doppler Evaluation of Diastolic Dysfunction in Emergency Department Non-ST Elevation Acute Coronary Syndromes (TEDDy-NSTEACS) |
| Q47192685 | Defining Quality in Cardiovascular Imaging: A Scientific Statement From the American Heart Association. |
| Q38492653 | Diagnostic accuracy and utility of coronary CT angiography with consideration of unevaluable results: A systematic review and multivariate Bayesian random-effects meta-analysis with intention to diagnose |
| Q47903182 | Do we really need high-sensitivity troponin immunoassays in the emergency department? Maybe not. |
| Q37276851 | Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices™ systematic review |
| Q30358653 | Evidence synthesis to inform model-based cost-effectiveness evaluations of diagnostic tests: a methodological review of health technology assessments |
| Q40070422 | External Validation of the Manchester Acute Coronary Syndromes Decision Rule |
| Q39330578 | Head-to-head comparison of cardiac troponin T and troponin I in patients without acute coronary syndrome: a systematic review. |
| Q33786119 | High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation |
| Q39223912 | High-sensitivity assays for troponin in patients with cardiac disease |
| Q36613661 | High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study |
| Q26738522 | High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages |
| Q38473964 | ITERATIVE SIFTING IN THE SELECTION OF RESEARCH EVIDENCE: IMPLICATIONS FOR REVIEWS AND OTHER DECISION PROBLEMS. |
| Q37525860 | Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction. |
| Q26862861 | Improving search efficiency for systematic reviews of diagnostic test accuracy: an exploratory study to assess the viability of limiting to MEDLINE, EMBASE and reference checking |
| Q36978960 | Inductive and Deductive Approaches to Acute Cell Injury |
| Q40605415 | Personality factors and depression as predictors of hospital-based health care utilization following acute myocardial infarction |
| Q58767646 | Received care compared to ADP-guided care of patients admitted to hospital with chest pain of possible cardiac origin |
| Q26769732 | Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment |
| Q37480773 | The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA) - a multicentre parallel-group randomised trial to compare early computerised tomography coronary angiography versus standard care in patients presenting with sus |
| Q38647973 | The cost-utility of point-of-care troponin testing to diagnose acute coronary syndrome in primary care |
| Q38948903 | The incremental value of stress testing in patients with acute chest pain beyond serial cardiac troponin testing |
| Q38732124 | The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis. |
| Q35821307 | The ultimate nanoscale mincer: assembly, structure and active sites of the 20S proteasome core. |
| Q48102011 | Translational health economics: The key to accountable adoption of in vitro diagnostic technologies. |
| Q39268332 | Using expert elicitation to estimate the potential impact of improved diagnostic performance of laboratory tests: a case study on rapid discharge of suspected non-ST elevation myocardial infarction patients. |
Search more.